Quick Answer
Microbot Medical Inc. reported Stockholders Equity of $77.55 million for the year ending 2025.
- Microbot Medical Inc. showed an increase of +2,097.0% in Stockholders Equity from 2024 to 2025.
- This data is from Microbot Medical Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $7.50 million | Q3 2018: $6.07 million | Q1 2019: $9.23 million | Q2 2019: $7.98 million | Q3 2019: $6.40 million | Q1 2020: $29.68 million | Q2 2020: $28.39 million | Q3 2020: $26.48 million | Q1 2021: $22.33 million | Q2 2021: $20.12 million | Q3 2021: $17.87 million | Q1 2022: $11.62 million | Q2 2022: $8.54 million | Q3 2022: $5.53 million | Q1 2023: $4.85 million | Q2 2023: $9.47 million | Q3 2023: $7.36 million | Q1 2024: $6.17 million | Q2 2024: $6.06 million | Q3 2024: $3.81 million | Q1 2025: $28.95 million | Q2 2025: $30.36 million | Q3 2025: $78.22 million.
- Over the full 18 years of available data (2008 to 2025), Microbot Medical Inc.'s Stockholders Equity has grown by 255.6%.
- Historical annual values: Fiscal year 2025: $77.55 million | Fiscal year 2024: $3.53 million | Fiscal year 2023: $4.50 million | Fiscal year 2022: $7.29 million | Fiscal year 2021: $14.38 million | Fiscal year 2020: $24.31 million | Fiscal year 2019: $31.54 million | Fiscal year 2018: $1.33 million | Fiscal year 2017: $9.99 million | Fiscal year 2016: $1.70 million | Fiscal year 2015: -$64.0 thousand | Fiscal year 2014: $857.0 thousand | Fiscal year 2013: $14.95 million | Fiscal year 2012: $13.98 million | Fiscal year 2011: $10.73 million | Fiscal year 2010: $15.48 million | Fiscal year 2009: $30.50 million | Fiscal year 2008: $21.81 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: